Patient Education Guide
Wegovy Pill: Switching from Injection to Tablet
The Key Message: Switching from a weight loss injection to the Wegovy Pill is a clinically straightforward process — but it requires a proper prescription review, not a self-managed change. The switch pathway differs depending on whether you are coming from the Wegovy 2.4mg injection, the Wegovy 7.2mg injection, or Mounjaro. If you are switching from the Wegovy injection, you can usually move straight onto the 25mg pill — the maintenance dose — without working back up from the lowest dose, because you already have therapeutic semaglutide levels. Switching from Mounjaro is different: as it contains a different medicine, you start the pill at the lowest 1.5mg dose and build up over approximately four months. This guide explains what that process involves, what prescribers and pharmacists assess before approving a switch, and what to expect during the transition.Day 8Typical start date for Wegovy Pill after last injection
25mgPill dose you switch straight to from the Wegovy injection
1.5mgStarting dose when switching from Mounjaro, then titrate up
Motivation
1. Why Patients Switch from Injection to Tablet
The Wegovy Pill was approved by the MHRA in June 2026, and since its launch a number of patients already established on weight loss injections have enquired about switching. The reasons are varied — and understanding your own motivation for switching is an important first step, because it helps set realistic expectations about what the transition will involve.
| Reason for switching | What a prescriber will want to discuss |
|---|---|
| Needle anxiety or injection discomfort | The pill fully removes the need for injections — a straightforward, well-supported reason to switch if results have been satisfactory |
| Preference for a daily tablet routine | The Sip & Go routine is daily but requires a consistent morning fasted window — the prescriber will check this is practical for your lifestyle |
| Injection site reactions or skin irritation | The pill eliminates injection site issues entirely — a clear clinical benefit for affected patients |
| Wanting a less visible or more discreet treatment | A tablet is easier to take without colleagues or others noticing — a valid lifestyle consideration |
| NHS injection supply issues or cost pressure | The pill is not yet NHS-funded; private cost is similar to or potentially lower than some injectable options — worth comparing with your pharmacist |
| Curiosity about the new formulation | A valid reason, but the prescriber will ensure expectations about results — particularly if switching from a higher-efficacy injection — are realistic |
| Wanting to stop injections after reaching goal weight | Often combined with a broader discussion about long-term maintenance strategy and when or whether to continue treatment |
Your Route Across
2. The Three Switch Pathways
The approach your prescriber and pharmacist will take depends on which injection you are currently taking and at what dose. The Wegovy Pill contains semaglutide — the same active ingredient as the Wegovy injection, but a different agent from Mounjaro (tirzepatide). This distinction matters clinically, and the switch pathways reflect it.
Equivalent Pill Doses When Crossing Over Mid-Titration
If you have not yet reached the top of your injection schedule, your prescriber may move you across to the matching tablet dose rather than restarting at the lowest dose. The pairings below are the equivalent doses a prescriber is likely to use. Because oral semaglutide is absorbed more variably than the injection, these are a practical guide rather than an exact conversion — your prescriber confirms the right dose and may adjust it for you.
Patients on the 2.4mg or 7.2mg injection switch straight to the 25mg pill; the lower-dose pairings are a prescriber-led option for those still building up. Switches from Mounjaro always start at 1.5mg and titrate up.
Switching from Wegovy 2.4mg Injection
Same active ingredient — clean, direct transition
- 1Take your last 2.4mg injection as normal
- 2Wait 7 days (your normal injection interval)
- 3Begin Wegovy Pill at 25mg on Day 8 — straight to the maintenance dose
- 4No titration needed — your semaglutide levels are already therapeutic
- 5Prescriber to review at 12 weeks
Clinical review required
Switching from Wegovy 7.2mg Injection
Discuss expectations with your prescriber before switching
- 1Take your last 7.2mg injection as normal
- 2Wait 7 days (your normal injection interval)
- 3Begin Wegovy Pill on Day 8 — usually straight to 25mg, at prescriber's discretion
- 4No routine titration — you already tolerate a higher dose
- 5Monitor weight — the 25mg pill is a step down in strength
Clinical review essential
Switching from Mounjaro (Any Dose)
Different active ingredient — expect a different response
- 1Take your last Mounjaro injection as normal
- 2Wait 14 days
- 3Begin Wegovy Pill at 1.5mg on Day 14 — titration needed
- 4Build up: 1.5mg → 4mg → 9mg → 25mg over ~4 months
- 5Monitor for return of appetite and adjust lifestyle support; allow 8–12 weeks at 25mg to assess the full effect
| Current Wegovy injection dose (once weekly) | Equivalent Wegovy Pill dose (once daily) |
|---|---|
| 0.25mg | 1.5mg |
| 0.5mg | 4mg |
| 1mg or 1.7mg | 9mg |
| 2.4mg or 7.2mg | 25mg |
⚠️ Switching from the Wegovy Injection? You Go Straight to the 25mg Pill
If you are established on the Wegovy injection (2.4mg or 7.2mg), you do not need to work back up from the lowest dose. The 25mg pill produces a semaglutide level comparable to the 2.4mg injection, so you can switch directly to the 25mg maintenance dose one week after your last injection. Titration from 1.5mg is only needed when starting the pill from scratch or switching from Mounjaro, where no semaglutide is already on board. Your prescriber confirms the right starting dose for you — for some patients, or from lower injection doses, a more gradual build-up may still be chosen.
Clinical Review
3. What Your Prescriber and Pharmacist Will Assess
A switch from injection to tablet is a prescription change — not simply a product swap. At Happy Pharmacy, patients requesting a switch will undergo a clinical Consultation that covers a standard set of assessment areas. This is not bureaucratic caution: it is good clinical practice that protects your safety and gives you the best chance of a smooth, successful transition.
| Assessment area | Why it matters at switch consultation |
|---|---|
| Current treatment and dose | Which injection, at what dose, and for how long — this informs which switch pathway is appropriate |
| Reason for switching | Needle anxiety, lifestyle preference, convenience, or tolerability issues — relevant to counselling and managing expectations |
| Weight loss achieved to date | Helps set realistic expectations post-switch, particularly when moving from a higher-efficacy injection |
| Current side effect profile | Any persistent GI issues on the injection may recur or change on the pill — important context for the transition |
| Adherence to current injection routine | Patients who have struggled with weekly injection compliance may or may not find daily tablet compliance easier — worth exploring |
| Other medicines and supplements | Particularly oral HRT, thyroid medication, warfarin, and any medicines with narrow therapeutic windows |
| Contraception status | Effective contraception required throughout treatment — a switch consultation is the right time to confirm this |
| Morning routine and lifestyle | The Sip & Go routine requires a consistent fasted morning window — the pharmacist will assess whether this is practical |
| Understanding of the Sip & Go rules | Patients switching from injections are not automatically familiar with the oral absorption requirements — thorough counselling is essential |
| Expectations about results post-switch | Particularly for patients coming from 7.2mg or Mounjaro — the pill may produce less weight loss, and this should be discussed openly |
ℹ️ Why You Cannot Simply Swap Over Yourself
The Wegovy Pill is a prescription-only medicine. Stopping an existing prescription injection and starting the pill without a clinical review means going without any treatment during the gap — and starting a new medicine without the appropriate assessment, dose guidance, and monitoring plan. A proper switch Consultation typically takes only a few minutes but gives you the clinical oversight that safe treatment requires.
During the Switch
4. What to Expect During the Transition
Understanding what the transition period actually feels like — and what is normal versus what warrants a call to your prescriber — helps patients navigate the switch with confidence.
Increased Appetite During the Gap Week
The seven-day gap between your last injection and starting the pill is the period patients most commonly find challenging. As injectable semaglutide or tirzepatide levels decline, appetite suppression reduces — sometimes noticeably. Food noise may return, and hunger between meals may increase. This is a pharmacological effect of the drug clearing, not a sign that treatment has failed.
Practical strategies for the gap week include maintaining your existing meal pattern rather than listening to increased hunger signals, keeping high-calorie snacks out of the house, and staying well hydrated. The gap week is temporary — because you switch straight onto the 25mg pill, appetite suppression is restored quickly, typically within the first couple of weeks.
Side Effects When Switching Straight to 25mg
Patients who have already been on a weight loss injection may assume they will not experience nausea or gastrointestinal effects on the pill — because they tolerated the injection well. This assumption is worth revisiting. The pill and the injection deliver semaglutide differently. If you switch from the Wegovy injection you go straight to the 25mg pill, skipping the gradual build-up; because you already tolerate a comparable dose this is usually manageable, but some GI effects can still occur. If you are titrating up from Mounjaro, the step-by-step dose increases remain important and should not be rushed.
Switching from Mounjaro: Managing the Mechanism Change
Patients switching from Mounjaro to the Wegovy Pill are making a more significant pharmacological change than those switching between Wegovy formulations. Mounjaro activates both GLP-1 and GIP receptors; the Wegovy Pill activates GLP-1 only. For some patients, the loss of the GIP pathway results in a noticeable increase in appetite — particularly in the first few weeks after the switch, before the semaglutide dose has escalated to therapeutic levels.
Patients switching from Mounjaro should discuss with their prescriber what to expect and agree a monitoring plan. If appetite increases significantly and does not settle once the 25mg maintenance dose is established, it may be appropriate to reassess whether the Wegovy Pill is the right long-term choice — or whether a return to Mounjaro or a switch to the Wegovy 7.2mg injection would better serve their needs.
Week 1 — Day 1
Last Injection
Take your final injection dose as normal. Begin planning your morning Sip & Go routine ready to start the pill on Day 8.
Days 2–7
Washout Window
No treatment taken. Some patients notice increased appetite returning — this is normal as injection drug levels decline. Stay consistent with diet.
Week 2 (Day 8)
Start 25mg Pill
Begin the Sip & Go routine straight at the 25mg maintenance dose — no need to build up, because you are switching from the injection.
Months 1–3
Settle & Review
Your semaglutide levels reach steady state within about 4–5 weeks at the 25mg dose. Continue the daily routine and review with your prescriber at 12 weeks.
Building the Habit
5. Managing the Sip & Go Routine as a New Habit
For patients switching from injections, the Sip & Go daily routine represents a new behavioural requirement that weekly injections did not demand. Injection users are accustomed to a once-weekly administration with no timing restrictions. The pill asks for something different: a daily, fasted, morning-anchored routine with a 30-minute wait.
Most patients find that once the routine is established — typically within two to three weeks — it becomes automatic and requires little thought. The challenge is the first week or two, when the habit is new and the temptation to have a coffee first thing is strong.
| Habit-building tip | Why it helps |
|---|---|
| Put your tablets next to your alarm or phone the night before | Removes the decision about where the tablets are — they are the first thing you see on waking |
| Pre-measure 120ml of plain water the night before in a dedicated small bottle | Eliminates the temptation to use the kettle or grab a glass of juice — your water is already ready |
| Set a 30-minute phone timer the moment you swallow the tablet | Takes the countdown out of your head — you do not need to watch the clock |
| Use the 30 minutes for a fixed activity — shower, get dressed, morning walk | Anchoring the wait to another habit makes it feel purposeful rather than passive |
| Tell someone in your household about the routine | Prevents well-meaning offers of tea or toast during the wait window |
| Keep a week-one habit tracker on your phone or a notepad | Visual streaks are a simple but effective motivation tool during the first weeks of a new routine |
Honest Expectations
6. What Happens to Your Weight During the Switch?
This is the question most patients switching from injections want answered honestly. The short answer is: it depends on which injection you are switching from.
Switching from Wegovy 2.4mg Injection
Patients switching from the standard 2.4mg Wegovy injection to the pill are moving between two treatments with broadly equivalent average efficacy (~17% weight loss over 68 weeks), and the 25mg pill gives a comparable semaglutide level. A well-managed switch — with a clean seven-day gap and a direct switch to the 25mg pill dose — should result in broadly stable weight over the transition, with continued progress on the maintenance dose. Any temporary weight change during the gap week is possible but typically modest.
Switching from Wegovy 7.2mg Injection
This switch carries a meaningful step-down in expected efficacy. The 7.2mg injection produces approximately 20.7% average weight loss versus 14-17% for the pill. Patients should expect that some weight regain is possible during the transition and that the pill's maintenance results will be lower than what they may have achieved on the higher injection dose. This is not a reason to avoid the switch if needle-free treatment is the priority — but it is important information for setting realistic expectations.
Switching from Mounjaro
Mounjaro's average weight loss of ~22.5% at the 15mg dose is higher than the Wegovy Pill's ~14-17%. Patients switching from Mounjaro should have a frank conversation with their prescriber about the likelihood of some weight regain and the importance of strong lifestyle support during the transition. The magnitude of any regain will depend on how well appetite is managed during the gap and early escalation phase, and on how effectively the 25mg pill dose suppresses appetite for that individual.
ℹ️ Weight During the Switch Is Not the Whole Picture
Weight fluctuations of one to three kilograms during a treatment switch are common and are influenced by fluid balance, dietary variation, and the pharmacological gap between treatments. A single weigh-in during the transition does not tell the full story. The meaningful assessment of a switch's success is weight at 8–12 weeks after reaching the 25mg maintenance dose — not weight in the first month of switching.
💡 Give the Pill Time Before Making a Judgement
The Wegovy Pill does not reach its full treatment effect until several weeks at the 25mg maintenance dose. A proper assessment of how well the switch has worked should not be made until at least 8–12 weeks at 25mg. If you switched straight onto 25mg from the Wegovy injection, that point comes sooner; if you titrated up from Mounjaro, allow roughly six months from starting the pill. Judging the pill's effectiveness too early, or immediately after switching from a more potent injection, will underestimate its eventual impact.
Honest Guidance
7. When Switching May Not Be the Right Decision
The Wegovy Pill is an excellent choice for many patients — but it is not the right choice for everyone currently on an injection. A good prescriber will support the switch where appropriate and offer honest guidance where it is not.
| Situation | Prescriber likely to advise |
|---|---|
| You are achieving excellent results on the 7.2mg injection and have no strong reason to switch | Continue with the injection — the efficacy advantage is meaningful and should not be surrendered without a compelling reason |
| You have a history of poor medication adherence with daily tablets | Discuss honestly — a once-weekly injection may actually be more reliably taken than a daily tablet requiring a specific morning routine |
| Your daily schedule makes a consistent fasted morning window genuinely difficult | The injection's flexibility may be a better long-term fit; if the switch is still desired, a practical plan for the morning routine is needed first |
| You are in the middle of active weight loss on Mounjaro and close to your target | Consider completing your course before switching, rather than disrupting a successful trajectory |
| You have struggled with GI side effects on the injection | The pill may produce similar or different GI effects — this is worth discussing, not assuming the pill will be easier to tolerate |
| You want to switch to reduce cost | Compare private costs carefully — the pill's price has not been confirmed; ensure cost savings are real before making a clinically motivated switch for financial reasons |
Common Questions
Frequently Asked Questions
Yes — switching from Mounjaro to the Wegovy Pill is clinically possible and requires a prescription review and Consultation. The key considerations are the mechanism difference (GLP-1 plus GIP versus GLP-1 only), the step-down in average efficacy, and the need to start the pill at 1.5mg and titrate up — because, unlike a switch from the Wegovy injection, no semaglutide is already on board. Your prescriber will discuss what to expect and agree a monitoring plan. Happy Pharmacy's clinical team can guide you through this process.
Not if you are switching from the Wegovy injection. Because the 25mg pill gives a semaglutide level comparable to the 2.4mg injection, patients established on the Wegovy injection (2.4mg or 7.2mg) can usually switch straight to the 25mg pill on Day 8, without working up from 1.5mg. Starting at 1.5mg and titrating up is needed when beginning the pill from scratch or switching from Mounjaro, where no semaglutide is already on board. Your prescriber confirms the right starting dose for you; from lower injection doses, or where tolerability is a concern, a more gradual build-up may still be chosen.
Some temporary weight fluctuation is normal during any treatment switch. The gap week between your last injection and first pill can result in modest weight variation. Patients switching from the Wegovy injection go straight to the 25mg pill, so therapeutic levels are restored quickly; those titrating up from Mounjaro have a longer ramp where appetite may return. For patients coming from higher-efficacy treatments (7.2mg or Mounjaro), some weight regain is possible over the transition. This should be discussed openly with your prescriber before the switch.
If you switch from the Wegovy injection, you start the 25mg pill on Day 8 and reach steady semaglutide levels within about four to five weeks. If you titrate up from Mounjaro, reaching the 25mg dose takes around four months. Either way, a meaningful assessment should be made 8–12 weeks after you are settled on the 25mg maintenance dose, at which point the full treatment effect of the pill is established.
Yes — switching back is possible under clinical supervision. If the Wegovy Pill proves difficult to take consistently, produces inadequate results, or does not suit your lifestyle, your prescriber can support a return to an injection. Any switch — in either direction — requires a Consultation and prescription review.
No — the timing is based on the interval from your last injection (seven days), not the day of the week. If your last Wegovy injection was on a Tuesday, you would start the pill on the following Tuesday. Your prescriber will confirm the specific start date at your switch consultation.
Thinking About Switching to the Wegovy Pill?
Happy Pharmacy is a GPhC-registered online pharmacy (No. 9012585). Our clinical team has experience supporting patients switching between weight loss treatments and will guide you through every step — from your switch consultation to your first Sip & Go morning. Trustpilot Rating: 4.8 ★
Book Your Free Consultation →
1. Weight regain and cardiometabolic effects after withdrawal of semaglutide. Diabetes, Obesity and Metabolism. 2022;24(8):1553–1564. | 2. Once Weekly for the Treatment of Obesity (SURMOUNT-1). New England Journal of Medicine. 2022;387:205–216. | 3. Oral semaglutide 50mg taken once per day in adults with overweight or obesity (OASIS 1). Lancet. 2023;402(10403):705–719. | 4. Efficacy and Safety of Semaglutide 7.2mg in Obesity — STEP UP Trial. American Diabetes Association, 2025. | 5. Electronic Medicines Compendium. Wegovy 1.5mg–25mg film-coated tablets — Summary of Product Characteristics. Novo Nordisk, 2026. | 6. MHRA. Wegovy (semaglutide) oral tablet — approval summary. GOV.UK, June 2026. | Happy Pharmacy (GPhC No. 9012585). The information in this guide reflects general clinical practice guidance for switching between weight loss treatments in the UK as of June 2026. Individual switch pathways should always be agreed with a qualified prescriber following a clinical assessment. Do not stop or switch any prescription medicine without professional advice.